Parents and Babies Pilot (PAB)
3. august 2026 oppdatert av: Leiszle Rae Lapping-Carr, Northwestern University
Parents and Babies: Pilot Testing an Inclusive Preventive Postpartum Depression Intervention
The goal of this study will be piloting the Parents and Babies perinatal depression prevention intervention to examine its feasibility and acceptability and to obtain preliminary data on its efficacy.
This includes exploring/understanding users' experiences navigating the interventions (e.g., from an implementation perspective) and preliminary evaluations of clinical outcomes, including mental health and minority stress.
With data gathered from this pilot study, we will make final adaptations to the Parents and Babies manuals and plan to develop a randomized-control trial to evaluate efficacy of the intervention.
Studieoversikt
Status
Rekruttering
Studietype
Intervensjonell
Registrering (Antatt)
16
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60611
- Rekruttering
- Northwestern University
-
Ta kontakt med:
- Leiszle Lapping-Carr
- Telefonnummer: 312- 503-3814
- E-post: parentsandbabies@northwestern.edu
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- self-identify as LGBTQ+
- 18 years old or older
- live in the USA or territories
- speak and understand English
- Currently pregnant or within one year of childbirth
- Endorse current mild depressive symptoms or risk factors for postpartum depression
Exclusion Criteria:
- Are unable to consent/have impaired decision making capacity
- Have current active suicidal or homicidal ideation, active psychosis, or current mania
- Are currently experiencing a severe depressive episode
- Do not have audio and/or video capacity for attending group sessions remotely.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Virtual Group
Sessions will be delivered virtually.
Includes participants from across the US.
|
Parents and Babies is a 10-session intervention adapted from Mothers and Babies, a nationally recognized intervention for depression during pregnancy and postpartum built on principles of cognitive-behavioral therapy (CBT), attachment theory, and psychoeducation.
Sessions are delivered virtually and led by a clinical psychologist.
|
|
Eksperimentell: Hybrid Group
Sessions will be delivered virtually with three hybrid sessions with options for in-person attendance.
Includes only participants located in the Chicagoland area.
|
Parents and Babies is a 10-session intervention adapted from Mothers and Babies, a nationally recognized intervention for depression during pregnancy and postpartum built on principles of cognitive-behavioral therapy (CBT), attachment theory, and psychoeducation.
Sessions are delivered virtually and led by a clinical psychologist, with an option for in-person participation at three sessions.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Implementation of Parents and Babies skills
Tidsramme: T2 (immediately post-intervention), T3 (3-months post-intervention)
|
Parents and Babies Skill Utilization Survey - 8 item questionnaire to determine the extent to which one agrees that the PAB course taught skills related to the core modules, was useful, and was easy to understand; using a 5-point Likert scale (1 = strongly disagree, 5 = strongly agree).
|
T2 (immediately post-intervention), T3 (3-months post-intervention)
|
|
Patient Health Questionnaire - 9 (PHQ-9)
Tidsramme: T1 (prior to starting intervention), T2 (immediately post-intervention), T3 (3 months post-intervention)
|
The Patient Health Questionnaire-9 is the 9 item depression module of the Patient Health Questionnaire.
It scores each of the 9 DSM-IV criteria as "0" (not at all) to "3" (nearly every day).
Higher scores indicate an increased severity of depression symptoms.
|
T1 (prior to starting intervention), T2 (immediately post-intervention), T3 (3 months post-intervention)
|
|
Perceived Stress Scale (PSS-10)
Tidsramme: T1 (prior to starting intervention), T2 (immediately post-intervention), T3 (3 months post-intervention)
|
The Perceived Stress Scale (PSS-10; Cohen, Kamarch, & Mermelstein,1983) is a 10 item measure of the degree to which situations in one's life are appraised as stressful with responses rated on a 5-point Likert scale (0 =never to 4 =very often).
Higher scores indicate greater perceived stress.
|
T1 (prior to starting intervention), T2 (immediately post-intervention), T3 (3 months post-intervention)
|
|
Generalized Anxiety Disorder Scale (GAD-7)
Tidsramme: T1 (prior to starting intervention), T2 (immediately post-intervention), T3 (3 months post-intervention)
|
The Generalized Anxiety Disorder Scale (Spitzer et.al, 2006) is a 7 item self-report measure used to assess anxiety.
Participants are queried regarding symptoms during the past two weeks and responses are tallied on a four-point Likert scale.
(0 = not at all to 3=nearly every day.)
Higher scores indicate an increased severity of anxiety symptoms.
|
T1 (prior to starting intervention), T2 (immediately post-intervention), T3 (3 months post-intervention)
|
|
Multidimensional Scale of Perceived Social Support (MSPSS)
Tidsramme: T1 (prior to starting intervention), T2 (immediately post-intervention), T3 (3 months post-intervention)
|
The Multidimensional Scale of Perceived Social Support (Zimet et al. 1988) is a 12-item measure of perceived adequacy of social support from three sources: family, friends, & significant other; using a 5-point Likert scale (0 = strongly disagree, 5 = strongly agree).
Higher scores in each subscale indicate greater perceived support from that source.
|
T1 (prior to starting intervention), T2 (immediately post-intervention), T3 (3 months post-intervention)
|
|
The Acceptability of Intervention Measure (AIM)
Tidsramme: T2 (immediately post-intervention)
|
The Acceptability of Intervention Measure (Weiner et al., 2017) is a four-item measure of implementation outcomes to determine the extent to which one believes an intervention is appealing and satisfactory on a 5-point Likert scale (1 = completely disagree to 5 = completely agree).
Higher scores indicate greater perceived acceptability of the intervention.
|
T2 (immediately post-intervention)
|
|
Intervention Appropriateness Measure (IAM)
Tidsramme: T2 (immediately post-intervention)
|
Intervention Appropriateness Measure (Weiner et al., 2017) is a four-item measure evaluating the extent to which one believes an intervention is suitable, relevant, compatible, and applicable to one's needs on a 5-point Likert scale (1 = completely disagree to 5 = completely agree).
Higher scores indicate greater perceived appropriateness of the intervention.
|
T2 (immediately post-intervention)
|
|
Feasibility of Intervention Measure (FIM)
Tidsramme: T2 (immediately post-intervention)
|
Feasibility of Intervention Measure (Weiner et al., 2017) is a four-item survey measuring the perceived feasibility of an intervention on a 5-point Likert scale (1 = completely disagree to 5 = completely agree).
Higher scores indicate greater perceived feasibility of the intervention.
|
T2 (immediately post-intervention)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Samarbeidspartnere
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
3. august 2026
Primær fullføring (Antatt)
1. april 2027
Studiet fullført (Antatt)
1. april 2027
Datoer for studieregistrering
Først innsendt
19. mai 2026
Først innsendt som oppfylte QC-kriteriene
19. mai 2026
Først lagt ut (Faktiske)
26. mai 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
6. august 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
3. august 2026
Sist bekreftet
1. august 2026
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- STU00225523
- 5K23MD018092-03 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
UBESLUTTE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .